刘驯教授中西医结合治疗2型糖尿病经验辑要
Summary of Professor Liu Xun’s Experience in the Treatment of Type 2 Diabetes with Integrated Traditional Chinese and Western Medicine
DOI: 10.12677/TCM.2023.126198, PDF,   
作者: 万喜凤, 赵丰抗：湖北中医药大学第一临床学院，湖北 武汉；刘 驯：湖北中医药大学第一临床学院，湖北 武汉；湖北中医药大学附属江津中医院，重庆
关键词: 刘驯；消渴症；2型糖尿病；中西医结合；Liu Xun； Diabetes Disease； Type 2 Diabetes； Integrated Chinese and Western Medicine
摘要: 刘驯主任医师通过中西医结合治疗2型糖尿病久病伴并发症患者，认为2型糖尿病出现并发症的主要病机脾虚湿滞、痰瘀阻络，治法当以祛湿健脾、温肾利水、活血化瘀三法并行，调和诸脏，并且重视对患者进行情志疏导，临床控制患者血糖常常效如桴鼓。
Abstract: Liu Xun, chief physician, treated patients with type 2 diabetes mellitus with complications by combining traditional Chinese and western medicine. Liu Xun believes that the main pathogenesis of complications of type 2 diabetes is dampness stagnation of spleen deficiency and obstruction of collaterality by phlegm and blood stasis. The treatment methods are combined with three methods: removing dampness and invigorating spleen, warming kidney and benefiting water, promoting blood circulation and removing blood stasis. Besides, he attaches great importance to the emotional guidance of patients, and has achieved good clinical effect in controlling the blood sugar of patients.
文章引用：万喜凤, 赵丰抗, 刘驯. 刘驯教授中西医结合治疗2型糖尿病经验辑要[J]. 中医学, 2023, 12(6): 1328-1331. https://doi.org/10.12677/TCM.2023.126198

参考文献

[1] Deacon, C.F. (2011) Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes: A Comparative Review. Diabetes, Obesity and Metabolism, 13, 7-18. [Google Scholar] [CrossRef] [PubMed]
[2] Michael, S., Barry, J.G. and Timon, W.H. (2005) Type 2 Diabetes: Principles of Pathogenesis and Therapy. The Lancet, 365, 1333-1346. [Google Scholar] [CrossRef] 
[3] 胡浩, 刘媛媛, 孙进, 等. 达格列净治疗2型糖尿病合并代谢综合征患者的临床观察及对心脑血管疾病的预防分析[J]. 现代医学与健康研究电子杂志, 2023, 7(8): 58-60.
[4] 肖魏华, 万珍英. 甘精胰岛素联合阿卡波糖对高龄2型糖尿病患者血糖及胰岛素分泌指数的影响[J]. 检验医学与临床, 2023, 20(7): 991-994.
[5] Nishimura, R., Takeshima, T., Iwasaki, K. and Aoi, S. (2023) Prescription Patterns and Therapeutic Effects of Second- Line Drugs in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Claims Data for Metformin and Dipeptidyl Peptidase-4 Inhibitors as the First-Line Hypoglycemic Agents. Expert Opinion on Pharmacotherapy, 24, 969-976. [Google Scholar] [CrossRef] [PubMed]
[6] Abiru, N., Nakatsuji, Y., Noguchi, M. and Tsuboi, K. (2023) Overlapping Risk Factors for Diabetic Ketoacidosis in Patients with Type 1 Diabetes on Ipragliflozin: Case Analysis of Spontaneous Reports in Japan from a Pharmacovigilance Safety Database. Expert Opinion on Drug Safety. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, H., Cordiner, R.L.M., Huang, Y., Donnelly, L., Hapca, S., Collier, A., et al. (2023) Cardiovascular Safety in Type 2 Diabetes with Sulfonylureas as Second-Line Drugs: A Nation-Wide Population-Based Comparative Safety Study. Diabetes Care, 46, 967-977. [Google Scholar] [CrossRef] [PubMed]
[8] 林靖, 张杰文, 季兵. 补肾健脾方对2型糖尿病合并非酒精性脂肪肝患者脂肪肝的影响[J]. 河北中医, 2023, 45(2): 228-231.
[9] 马凌云, 刘爱茹, 张娜娜, 等. 滋阴补阳、消渴健骨汤对2型糖尿病合并骨质疏松症(阴阳两虚证)的治疗作用[J]. 辽宁中医药大学学报, 2023, 25(6): 141-145.
[10] Zhang, Z., Leng, Y., Chen, Z., Fu, X., Liang, Q., Peng, X., Xie, H., Gao, H. and Xie, C. (2023) The Efficacy and Safety of Chinese Herbal Medicine as an Add-On Therapy for Type 2 Diabetes Mellitus Patients with Carotid Atherosclerosis: An Updated Meta-Analysis of 27 Randomized Controlled Trials. Frontiers in Pharmacology, 14, Article ID: 1091718. [Google Scholar] [CrossRef] [PubMed]
[11] 王海焱, 秦灵灵, 刘铜华, 等. 中药复方糖耐康结合西医常规疗法治疗2型糖尿病足临床研究[J]. 国际中医中药杂志, 2022, 44(12): 1358-1364.
[12] 吴勉华, 王新月. 中医内科学[M]. 北京: 中国中医药出版社, 2012: 384.
[13] 王殿文, 王新慧, 李艺含, 等. 基于”痰瘀互结”理论辨治糖尿病肾病思路探析[J]. 环球中医药, 2023, 16(2): 296-299.
[14] 郑文静. 丹瓜化浊祛瘀汤治疗痰瘀互结型糖尿病下肢血管病变60例[J]. 浙江中医杂志, 2021, 56(10): 732.
[15] 赵光辉. 蒙药珍宝丸治疗糖尿病周围神经病变痰瘀互阻证的临床效果[J]. 中国民族医药杂志, 2021, 27(7): 14-16.